Medroxyprogesterone Acetate Injectable Suspension

Medroxyprogesterone acetate · Hikma Pharmaceuticals USA Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Medroxyprogesterone Acetate Injectable Suspension, covering 2023-01-05 to 2023-01-05. Get the full timeline:

Most recent: FDA Approved: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION — Original Application (Hikma Pharmaceuticals USA Inc.)